Common Decreased appetite Low blood sugar (Hypoglycaemia) when used with Metformin, Dapaglifozin, Empaglifozin and Canaglifozin Allergic reaction (e.g., rash, itching and eczema) Dizziness Decreased Low blood pressure Indigestion Bloating Burping Gas (flatulence) Fatigue Reflux or heart burn Fast pulse Injection site reaction (e.g., itching and redness) Increased levels of pancreatic enzymes (such as lipase and amylase) in blood Increased calcitonin levels in blood Gallstones Symptoms of hypoglycaemia include : Dizziness, sweating, feeling tired, tingling lips, feeling hungry, feeling shaky or trembling, fast or pounding heartbeat and turning pale
There have been rare associations with pancreatitis
Methods Adults ( 18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index
In May 2022 , the U.S
The Bottom Line Foundayo (orforglipron) is a genuinely novel development in GLP-1 therapy